Abstract 930: Production of functionally active recombinant FOXA1: The first step towards targeted drug discovery
Hariprasad Thangavel(Hackensack Meridian Health), Meghana V. Trivedi(University of Houston), Xiaoyong Fu(King University), Kurt R. Christensen(Baylor College of Medicine), Dean Edwards(Baylor College of Medicine), Yingmin Zhu(Baylor College of Medicine), Rachel Schiff(Baylor College of Medicine)
Cited by 0
Related Papers
Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance
|Endocrine Reviews|2008|545
Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function
|Cancer Research|2008|494
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485